CA19-9 0,1 mL
Specificity and Comments:
CA 19-9, a carbohydrate antigenic determinant identified as a sialylated lacto-N-fucopentose II, is related to the Lewis blood group. The CA19-9 antibody has been shown to label adenocarcinomas of the pancreas, stomach, colon and gall bladder. CA 19-9 is also expressed in primary and metastatic ovarian carcinomas.
Species Reactivity: Human; others not tested.
Clone: BC/121SLE
Isotype: IgM
Known Applications: Immunohistochemistry (formalin-fixed paraffin-embedded tissues)
Positive Control: Colon and ovarian cancer
Cellular Localization: Cytoplasmic
Supplied As:
Buffer with protein carrier and preservative
Storage and Stability:
Store at 4°C. Antibody is stable for 18 months.